Your browser doesn't support javascript.
loading
The value of biomarkers in diagnosis and treatment of heart failure with preserved ejection fraction retention / 中华检验医学杂志
Article in Zh | WPRIM | ID: wpr-1029873
Responsible library: WPRO
ABSTRACT
Heart failure with preserved ejection fraction (HFpEF)is a heterogeneous disease, and as a systemic syndrome, it presents different clinical course and prognosis. Currently, HF is not effective in its treatment. For the diagnosis and treatment of HFpEF, at present and in the future, should we focus more on the biomarkers involving the "crosstalk" between organs such as heart-liver-lung-kidney, based on the good application of existing commonly used markers, such as high-sensitivity troponin and BNP/NT-proBNP.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Laboratory Medicine Year: 2023 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Laboratory Medicine Year: 2023 Type: Article